Patents by Inventor David A. Wilcox

David A. Wilcox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLATELET TARGETED TREATMENT
    Publication number: 20240270822
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g.. clotting factors) to platelets.
    Type: Application
    Filed: August 7, 2023
    Publication date: August 15, 2024
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • PLATELET TARGETED TREATMENT
    Publication number: 20190270791
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 5, 2019
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Platelet targeted treatment
    Patent number: 10294291
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 21, 2019
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Platelet targeted treatment
    Patent number: 9982034
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: May 29, 2018
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • PLATELET TARGETED TREATMENT
    Publication number: 20180009874
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: August 29, 2017
    Publication date: January 11, 2018
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • PLATELET TARGETED TREATMENT
    Publication number: 20150344541
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: October 24, 2013
    Publication date: December 3, 2015
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Wideband non-contact data link using X-ray sources to excite scintillating material receiving device
    Patent number: 5978438
    Abstract: A radiographic scanner (10) has a stationary gantry portion (12) defining a subject receiving region (16) and a rotating gantry portion (20) on which an imaging x-ray tube (22) is mounted. The rotating gantry portion (20) is rotatably mounted to the stationary gantry portion (12) for rotation about the subject receiving region (16). A slip ring assembly extending around the subject receiving region (16) connected with the stationary and rotating gantry portions, includes a scintillating optical fiber (44) mounted around the patient receiving region (16) to one of the rotating and stationary gantry portions. A communication x-ray tube (40) is mounted to the other gantry portion and directed such that radiation therefrom enters the scintillating optical fiber (44) from a lateral direction. The scintillating optical fiber (44) converts the incident x-rays (52) to light (58) and transmits the light (58) along its longitudinal axis.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: November 2, 1999
    Assignee: Picker International, Inc.
    Inventors: Theodore A. Resnick, David A. Wilcox, Rodney A. Mattson